Amber Therapeutics
Amber Therapeutics is developing the Picostim™ System, a fully implantable device that utilizes adaptive pudendal neuromodulation to treat mixed urinary incontinence by dynamically stimulating the pudendal nerve based on real-time physiological feedback. This therapy addresses the significant unmet need of over 40 million women in the U.S. suffering from this debilitating condition, with promising clinical results demonstrating improved quality of life.
Traction 4/10Founded 2021
London, United Kingdom · HQ
- Biotechnology
- Healthcare Technology
- Medical Devices
Updated 2 days ago
Funding
Funding not disclosed
OS
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Amber Therapeutics is developing the Picostim™ System, a fully implantable device that utilizes adaptive pudendal neuromodulation to treat mixed urinary incontinence by dynamically stimulating the pudendal nerve based on real-time physiological feedback. This therapy addresses the significant unmet need of over 40 million women in the U.S. suffering from this debilitating condition, with promising clinical results demonstrating improved quality of life.